$21.90
$0.00 (0.00%)
End-of-day quote: 05/04/2024
NasdaqGS:EXEL
Exelixis Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | NYSE | Outperform | $127.51 | $130.51 | 0.00% | 11 | $322.99B |
| ROG | Roche Holding | SWX | Hold | CHF217.30 | CHF307.83 | 0.00% | 9 | CHF175.19B |
| PFE | Pfizer | NYSE | Outperform | $27.81 | $32.87 | 0.00% | 6 | $157.48B |
| REGN | Regeneron Pharmaceuticals | NasdaqGS | Outperform | $957.00 | $961.26 | 0.00% | 8 | $105.45B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $43.99 | $58.15 | 0.00% | 10 | $89.17B |
| BAYN | Bayer | XTRA | Hold | 28.02€ | 45.15€ | 0.00% | 4 | 27.53€B |
| 4523 | Eisai | TSE | Outperform | ¥6.55k | ¥9.58k | 0.00% | 0 | ¥1.86T |
| INCY | Incyte | NasdaqGS | Outperform | $53.76 | $77.05 | 0.00% | 8 | $11.89B |
| JAZZ | Jazz Pharmaceuticals | NasdaqGS | Outperform | $110.01 | $188.32 | 0.00% | 4 | $6.88B |
| BPMC | Blueprint Medicines | NasdaqGS | Outperform | $107.19 | $85.71 | 0.00% | 5 | $6.71B |
| IONS | Ionis Pharmaceuticals | NasdaqGS | Outperform | $41.97 | $55.60 | 0.00% | 3 | $6.12B |
